About T. Joseph Raoof, MD, Inc.
Clinical Trials at T. Joseph Raoof, MD, Inc.
During the past decade, T. Joseph Raoof, MD, Inc. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on
average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "T. Joseph Raoof, MD, Inc." #1 sponsor was "Pfizer" with 3 trials, followed by "Allergan" with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Promius Pharma, LLC" with 2 trials sponsored and "AnaptysBio, Inc."
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "T. Joseph Raoof, MD, Inc."
#1 collaborator was "Accelovance" with 1 trials as a collaborator and "Prosoft Clinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at T. Joseph Raoof, MD, Inc.
According to Clinical.Site data, the most researched conditions in "T. Joseph Raoof, MD, Inc." are
"Acne Vulgaris" (2 trials), "Cardiovascular Disease" (2 trials), "Migraine, With or Without Aura" (2 trials), "Onychomycosis" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "T. Joseph Raoof, MD, Inc." in a lesser frequency.
Clinical Trials Intervention Types at T. Joseph Raoof, MD, Inc.
Most popular intervention types in "T. Joseph Raoof, MD, Inc." are "Drug" (16 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Aqueous Gel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at T. Joseph Raoof, MD, Inc.
The vast majority of trials in "T. Joseph Raoof, MD, Inc." are
18 trials for "All" genders.
Clinical Trials Status at T. Joseph Raoof, MD, Inc.
Currently, there are NaN active trials in "T. Joseph Raoof, MD, Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in T. Joseph Raoof, MD, Inc.,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in T. Joseph Raoof, MD, Inc., 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".